Adherence rates during a randomized controlled trial evaluating the use of blinded acetaminophen and ibuprofen in children with asthma
When conducting clinical trials comparing over-the-counter (OTC) medications, the wide availability of these treatments are a potential challenge to maintaining study integrity. We seek to describe adherence to a study protocol involving widely available OTC medications. To prospectively evaluate as...
Saved in:
Published in | Contemporary clinical trials Vol. 104; p. 106334 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | When conducting clinical trials comparing over-the-counter (OTC) medications, the wide availability of these treatments are a potential challenge to maintaining study integrity. We seek to describe adherence to a study protocol involving widely available OTC medications.
To prospectively evaluate associations between acetaminophen use and asthma in 300 children aged 1–5 years, we conducted a double blind, randomized, controlled trial where parents administered blinded forms of either acetaminophen or ibuprofen as needed to their children over a 48 week period. Written and verbal instructions encouraged the exclusive use of the blinded study medication and discouraged OTC use. Adherence was determined by evaluating the frequency of use of per-protocol blinded study medication compared to off-protocol use of OTC medications.
4195 doses of acetaminophen or ibuprofen were received by children during the study which included 3664 doses (87.3%) of blinded study medication adhering to the protocol and 531 doses (12.7%) of OTC products deviating from the protocol with better adherence among those randomized to ibuprofen as compared to acetaminophen (89.5% vs. 85.5% of doses, p < 0.01). Individually, 227 participants (75.7%) remained fully adherent by not receiving any OTC medications. Pre-study preference for either acetaminophen or ibuprofen by the participants' families was not associated with differential rates of adherence to the blinded medication.
This parallel study demonstrated greater than 85% of acetaminophen or ibuprofen doses were blinded study medications adhering to the protocol while less than 15% were OTC deviations from the protocol. This successfully implemented study design provides a template to comparatively evaluate these and other OTC medications. |
---|---|
AbstractList | BACKGROUND/AIMSWhen conducting clinical trials comparing over-the-counter (OTC) medications, the wide availability of these treatments are a potential challenge to maintaining study integrity. We seek to describe adherence to a study protocol involving widely available OTC medications. METHODSTo prospectively evaluate associations between acetaminophen use and asthma in 300 children aged 1-5 years, we conducted a double blind, randomized, controlled trial where parents administered blinded forms of either acetaminophen or ibuprofen as needed to their children over a 48 week period. Written and verbal instructions encouraged the exclusive use of the blinded study medication and discouraged OTC use. Adherence was determined by evaluating the frequency of use of per-protocol blinded study medication compared to off-protocol use of OTC medications. RESULTS4195 doses of acetaminophen or ibuprofen were received by children during the study which included 3664 doses (87.3%) of blinded study medication adhering to the protocol and 531 doses (12.7%) of OTC products deviating from the protocol with better adherence among those randomized to ibuprofen as compared to acetaminophen (89.5% vs. 85.5% of doses, p < 0.01). Individually, 227 participants (75.7%) remained fully adherent by not receiving any OTC medications. Pre-study preference for either acetaminophen or ibuprofen by the participants' families was not associated with differential rates of adherence to the blinded medication. CONCLUSIONThis parallel study demonstrated greater than 85% of acetaminophen or ibuprofen doses were blinded study medications adhering to the protocol while less than 15% were OTC deviations from the protocol. This successfully implemented study design provides a template to comparatively evaluate these and other OTC medications. When conducting clinical trials comparing over-the-counter (OTC) medications, the wide availability of these treatments are a potential challenge to maintaining study integrity. We seek to describe adherence to a study protocol involving widely available OTC medications. To prospectively evaluate associations between acetaminophen use and asthma in 300 children aged 1–5 years, we conducted a double blind, randomized, controlled trial where parents administered blinded forms of either acetaminophen or ibuprofen as needed to their children over a 48 week period. Written and verbal instructions encouraged the exclusive use of the blinded study medication and discouraged OTC use. Adherence was determined by evaluating the frequency of use of per-protocol blinded study medication compared to off-protocol use of OTC medications. 4195 doses of acetaminophen or ibuprofen were received by children during the study which included 3664 doses (87.3%) of blinded study medication adhering to the protocol and 531 doses (12.7%) of OTC products deviating from the protocol with better adherence among those randomized to ibuprofen as compared to acetaminophen (89.5% vs. 85.5% of doses, p < 0.01). Individually, 227 participants (75.7%) remained fully adherent by not receiving any OTC medications. Pre-study preference for either acetaminophen or ibuprofen by the participants' families was not associated with differential rates of adherence to the blinded medication. This parallel study demonstrated greater than 85% of acetaminophen or ibuprofen doses were blinded study medications adhering to the protocol while less than 15% were OTC deviations from the protocol. This successfully implemented study design provides a template to comparatively evaluate these and other OTC medications. |
ArticleNumber | 106334 |
Author | Sheehan, William J. Robison, Rachel G. Szefler, Stanley J. Cabana, Michael D. Paul, Ian M. Moy, James N. Jackson, Daniel J. Covar, Ronina Phipatanakul, Wanda Mauger, David T. Fitzpatrick, Anne M. |
AuthorAffiliation | 2 Children’s National Hospital, Division of Allergy and Immunology and George Washington University School of Medicine and Health Sciences, Washington, DC 4 Penn State College of Medicine, Department of Public Health Sciences, Hershey, PA 9 University of California, San Francisco, Department of Pediatrics, San Francisco, CA 1 Boston Children’s Hospital, Division of Allergy and Immunology, Harvard Medical School, Boston, MA 6 Children’s Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 3 Penn State College of Medicine, Department of Pediatrics, Hershey, PA 8 Emory University, Department of Pediatrics, Atlanta, GA 10 National Jewish Health, Department of Pediatrics, Denver, CO 11 Ann and Robert H. Lurie Children’s Hospital of Chicago, Division of Allergy and Immunology, Chicago, IL 5 Stroger Hospital of Cook County and Department of Pediatrics, Rush University Medical Center, Chicago, IL 7 University of Wisconsin School of Medicine and Public Health |
AuthorAffiliation_xml | – name: 8 Emory University, Department of Pediatrics, Atlanta, GA – name: 1 Boston Children’s Hospital, Division of Allergy and Immunology, Harvard Medical School, Boston, MA – name: 5 Stroger Hospital of Cook County and Department of Pediatrics, Rush University Medical Center, Chicago, IL – name: 11 Ann and Robert H. Lurie Children’s Hospital of Chicago, Division of Allergy and Immunology, Chicago, IL – name: 10 National Jewish Health, Department of Pediatrics, Denver, CO – name: 4 Penn State College of Medicine, Department of Public Health Sciences, Hershey, PA – name: 6 Children’s Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO – name: 9 University of California, San Francisco, Department of Pediatrics, San Francisco, CA – name: 7 University of Wisconsin School of Medicine and Public Health, Section of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Madison, WI – name: 2 Children’s National Hospital, Division of Allergy and Immunology and George Washington University School of Medicine and Health Sciences, Washington, DC – name: 3 Penn State College of Medicine, Department of Pediatrics, Hershey, PA |
Author_xml | – sequence: 1 givenname: William J. surname: Sheehan fullname: Sheehan, William J. organization: Boston Children's Hospital, Division of Allergy and Immunology, Harvard Medical School, Boston, MA, United States of America – sequence: 2 givenname: Ian M. surname: Paul fullname: Paul, Ian M. organization: Penn State College of Medicine, Department of Pediatrics, Hershey, PA, United States of America – sequence: 3 givenname: David T. surname: Mauger fullname: Mauger, David T. organization: Penn State College of Medicine, Department of Public Health Sciences, Hershey, PA, United States of America – sequence: 4 givenname: James N. surname: Moy fullname: Moy, James N. organization: Stroger Hospital of Cook County, Department of Pediatrics, Rush University Medical Center, Chicago, IL, United States of America – sequence: 5 givenname: Stanley J. surname: Szefler fullname: Szefler, Stanley J. organization: Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, United States of America – sequence: 6 givenname: Daniel J. surname: Jackson fullname: Jackson, Daniel J. organization: University of Wisconsin School of Medicine and Public Health, Section of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Madison, WI, United States of America – sequence: 7 givenname: Anne M. surname: Fitzpatrick fullname: Fitzpatrick, Anne M. organization: Emory University, Department of Pediatrics, Atlanta, GA, United States of America – sequence: 8 givenname: Michael D. surname: Cabana fullname: Cabana, Michael D. organization: University of California, San Francisco, Department of Pediatrics, San Francisco, CA, United States of America – sequence: 9 givenname: Ronina surname: Covar fullname: Covar, Ronina organization: National Jewish Health, Department of Pediatrics, Denver, CO, United States of America – sequence: 10 givenname: Rachel G. surname: Robison fullname: Robison, Rachel G. organization: Ann and Robert H. Lurie Children's Hospital of Chicago, Division of Allergy and Immunology, Chicago, IL, United States of America – sequence: 11 givenname: Wanda surname: Phipatanakul fullname: Phipatanakul, Wanda email: wanda.phipatanakul@childrens.harvard.edu organization: Boston Children's Hospital, Division of Allergy and Immunology, Harvard Medical School, Boston, MA, United States of America |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33652129$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcuOFCEUhokZ41z0AdwYlm6q5VYFFROTycRbMokbXRMaTk3RoaAFqo0-gM8tbY8T3bjiP-E__znwXaKzmCIg9JySDSV0eLXbWFs3jDDa6oFz8Qhd0L4fO0Y4OfutaSepEOfospQdIXzoh_4JOudNMMrGC_Tz2s2QIVrA2VQo2K3ZxztsWhldWvwPcNimWHMKocmavQkYDiasph6NdQa8FsBpwtvgo2seY6Gaxce0nyHiFoP9dt3nNLXKR2xnH1wbib_5OmNT6ryYp-jxZEKBZ_fnFfry7u3nmw_d7af3H2-ubzsrCK-d5AqkleNIpJBETkwJKiyMXEkYpDJ2AEGVI0aNxIq2h-uVmWDqiR0IKMKv0JtT7n7dLuAstIeZoPfZLyZ_18l4_e9N9LO-SwetqCI9pS3g5X1ATl9XKFUvvlgIwURIa9FMjAMTktGhWenJanMqJcP0MIYSfeSnd7rx00d--sSv9bz4e7-Hjj_AmuH1yQDtlw4esi7WH_E5n6GFueT_E_8LMHqwXg |
Cites_doi | 10.1056/NEJMoa1515990 10.1177/0009922812462764 10.1111/j.1365-2222.2010.03610.x 10.1164/rccm.200409-1269OC 10.1016/j.jaci.2014.07.065 10.1016/j.jaci.2005.05.045 10.1542/peds.2010-3852 10.1111/j.1365-2222.2005.02151.x 10.1016/j.jaci.2007.09.029 10.1016/S0140-6736(08)61445-2 10.1542/peds.109.2.e20 10.1136/thx.2009.121459 10.1016/j.jaci.2010.08.023 10.1016/j.injury.2010.03.033 10.1136/bmjopen-2013-004324 10.1016/j.jaci.2016.09.028 10.1164/rccm.201005-0757OC 10.1542/peds.2008-2869 10.1542/peds.2011-1106 10.1111/cea.12433 |
ContentType | Journal Article |
Copyright | 2021 Elsevier Inc. Copyright © 2021 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2021 Elsevier Inc. – notice: Copyright © 2021 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.cct.2021.106334 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1559-2030 |
EndPage | 106334 |
ExternalDocumentID | 10_1016_j_cct_2021_106334 33652129 S1551714421000707 |
Genre | Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR000454 – fundername: NHLBI NIH HHS grantid: U10 HL098107 – fundername: NCATS NIH HHS grantid: UL1 TR002345 – fundername: NHLBI NIH HHS grantid: U10 HL098103 – fundername: NHLBI NIH HHS grantid: U10 HL098098 – fundername: NCATS NIH HHS grantid: UL1 TR000448 – fundername: NHLBI NIH HHS grantid: U10 HL098115 – fundername: NHLBI NIH HHS grantid: U10 HL098075 – fundername: NHLBI NIH HHS grantid: U10 HL098112 – fundername: NHLBI NIH HHS grantid: U10 HL098177 |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABBQC ABFNM ABJNI ABLJU ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM LCYCR M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 PC. Q38 RIG ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UAP Z5R ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c403t-738e7c799074707f28414ce9387e678ac6e418d0a890c4aced58afef50c60e803 |
IEDL.DBID | .~1 |
ISSN | 1551-7144 |
IngestDate | Tue Sep 17 21:13:51 EDT 2024 Fri Oct 25 08:21:09 EDT 2024 Thu Sep 26 17:52:29 EDT 2024 Sat Sep 28 08:19:40 EDT 2024 Fri Feb 23 02:44:45 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | RCT Acetaminophen Ibuprofen Children INFANT Randomized controlled trial AVICA Asthma OTC |
Language | English |
License | Copyright © 2021 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c403t-738e7c799074707f28414ce9387e678ac6e418d0a890c4aced58afef50c60e803 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-News-3 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180511 |
PMID | 33652129 |
PQID | 2496247216 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8180511 proquest_miscellaneous_2496247216 crossref_primary_10_1016_j_cct_2021_106334 pubmed_primary_33652129 elsevier_sciencedirect_doi_10_1016_j_cct_2021_106334 |
PublicationCentury | 2000 |
PublicationDate | 2021-05-01 |
PublicationDateYYYYMMDD | 2021-05-01 |
PublicationDate_xml | – month: 05 year: 2021 text: 2021-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Contemporary clinical trials |
PublicationTitleAlternate | Contemp Clin Trials |
PublicationYear | 2021 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | McBride (bb0045) 2011; 128 Ioannides, Williams, Jefferies (bb0085) 2014; 4 Shaheen, Newson, Henderson (bb0095) 2005; 35 Nichol, Bailey, Cooper, Polar, Investigators EPO (bb0005) 2010; 41 Sullivan, Farrar (bb0075) 2011; 127 Davey, Berhane, Duncan, Aref-Adib, Britton, Venn (bb0025) 2005; 116 Perzanowski, Miller, Tang (bb0090) 2010; 65 Lesko, Louik, Vezina, Mitchell (bb0010) 2002; 109 Vernacchio, Kelly, Kaufman, Mitchell (bb0040) 2009; 124 Schnabel, Heinrich, Group LS (bb0055) 2010; 126 Fitzpatrick, Jackson, Mauger (bb0065) 2016; 138 Sordillo, Scirica, Rifas-Shiman (bb0050) 2015; 135 Soferman, Tsivion, Farber, Sivan (bb0080) 2013; 52 Beasley, Clayton TO, Crane (bb0020) 2011; 183 McKeever, Lewis, Smit, Burney, Britton, Cassano (bb0030) 2005; 171 Beasley, Clayton, Crane (bb0015) 2008; 372 Wickens, Beasley, Town (bb0035) 2011; 41 Sheehan, Mauger, Paul (bb0060) 2016; 375 (EPR-3) EPR (bb0070) 2007; 120 Riley, Braithwaite, Shirtcliffe (bb0100) 2015; 45 McKeever (10.1016/j.cct.2021.106334_bb0030) 2005; 171 Davey (10.1016/j.cct.2021.106334_bb0025) 2005; 116 Sordillo (10.1016/j.cct.2021.106334_bb0050) 2015; 135 Soferman (10.1016/j.cct.2021.106334_bb0080) 2013; 52 Perzanowski (10.1016/j.cct.2021.106334_bb0090) 2010; 65 Lesko (10.1016/j.cct.2021.106334_bb0010) 2002; 109 Beasley (10.1016/j.cct.2021.106334_bb0015) 2008; 372 Sheehan (10.1016/j.cct.2021.106334_bb0060) 2016; 375 Fitzpatrick (10.1016/j.cct.2021.106334_bb0065) 2016; 138 Nichol (10.1016/j.cct.2021.106334_bb0005) 2010; 41 Beasley (10.1016/j.cct.2021.106334_bb0020) 2011; 183 Vernacchio (10.1016/j.cct.2021.106334_bb0040) 2009; 124 McBride (10.1016/j.cct.2021.106334_bb0045) 2011; 128 (EPR-3) EPR (10.1016/j.cct.2021.106334_bb0070) 2007; 120 Shaheen (10.1016/j.cct.2021.106334_bb0095) 2005; 35 Schnabel (10.1016/j.cct.2021.106334_bb0055) 2010; 126 Wickens (10.1016/j.cct.2021.106334_bb0035) 2011; 41 Ioannides (10.1016/j.cct.2021.106334_bb0085) 2014; 4 Riley (10.1016/j.cct.2021.106334_bb0100) 2015; 45 Sullivan (10.1016/j.cct.2021.106334_bb0075) 2011; 127 |
References_xml | – volume: 171 start-page: 966 year: 2005 end-page: 971 ident: bb0030 article-title: The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function publication-title: Am. J. Respir. Crit. Care Med. contributor: fullname: Cassano – volume: 135 start-page: 441 year: 2015 end-page: 448 ident: bb0050 article-title: Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children publication-title: J. Allergy Clin. Immunol. contributor: fullname: Rifas-Shiman – volume: 126 start-page: 1071 year: 2010 end-page: 1073 ident: bb0055 article-title: Respiratory tract infections and not paracetamol medication during infancy are associated with asthma development in childhood publication-title: J. Allergy Clin. Immunol. contributor: fullname: Group LS – volume: 52 start-page: 42 year: 2013 end-page: 48 ident: bb0080 article-title: The effect of a single dose of acetaminophen on airways response in children with asthma publication-title: Clin. Pediatr. (Phila) contributor: fullname: Sivan – volume: 116 start-page: 863 year: 2005 end-page: 868 ident: bb0025 article-title: Use of acetaminophen and the risk of self-reported allergic symptoms and skin sensitization in Butajira, Ethiopia publication-title: J. Allergy Clin. Immunol. contributor: fullname: Venn – volume: 45 start-page: 448 year: 2015 end-page: 456 ident: bb0100 article-title: Randomized controlled trial of asthma risk with paracetamol use in infancy--a feasibility study publication-title: Clin. Exp. Allergy contributor: fullname: Shirtcliffe – volume: 120 start-page: S94 year: 2007 end-page: 138 ident: bb0070 article-title: Guidelines for the diagnosis and management of asthma - Summary Report 2007 publication-title: J. Allergy Clin. Immunol. contributor: fullname: (EPR-3) EPR – volume: 65 start-page: 118 year: 2010 end-page: 123 ident: bb0090 article-title: Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort publication-title: Thorax contributor: fullname: Tang – volume: 183 start-page: 171 year: 2011 end-page: 178 ident: bb0020 article-title: Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three publication-title: Am. J. Respir. Crit. Care Med. contributor: fullname: Crane – volume: 109 year: 2002 ident: bb0010 article-title: Asthma morbidity after the short-term use of ibuprofen in children publication-title: Pediatrics contributor: fullname: Mitchell – volume: 124 start-page: 446 year: 2009 end-page: 454 ident: bb0040 article-title: Medication use among children <12 years of age in the United States: results from the Slone Survey publication-title: Pediatrics contributor: fullname: Mitchell – volume: 375 start-page: 619 year: 2016 end-page: 630 ident: bb0060 article-title: Acetaminophen versus ibuprofen in young children with mild persistent asthma publication-title: N. Engl. J. Med. contributor: fullname: Paul – volume: 138 year: 2016 ident: bb0065 article-title: Individualized therapy for persistent asthma in young children publication-title: J. Allergy Clin. Immunol. contributor: fullname: Mauger – volume: 41 start-page: 399 year: 2011 end-page: 406 ident: bb0035 article-title: The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort publication-title: Clin. Exp. Allergy contributor: fullname: Town – volume: 127 start-page: 580 year: 2011 end-page: 587 ident: bb0075 article-title: Fever and antipyretic use in children publication-title: Pediatrics contributor: fullname: Farrar – volume: 128 start-page: 1181 year: 2011 end-page: 1185 ident: bb0045 article-title: The association of acetaminophen and asthma prevalence and severity publication-title: Pediatrics contributor: fullname: McBride – volume: 41 start-page: S20 year: 2010 end-page: S23 ident: bb0005 article-title: Challenging issues in randomised controlled trials publication-title: Injury contributor: fullname: Polar, Investigators EPO – volume: 35 start-page: 18 year: 2005 end-page: 25 ident: bb0095 article-title: Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood publication-title: Clin. Exp. Allergy contributor: fullname: Henderson – volume: 372 start-page: 1039 year: 2008 end-page: 1048 ident: bb0015 article-title: Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme publication-title: Lancet contributor: fullname: Crane – volume: 4 year: 2014 ident: bb0085 article-title: Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults publication-title: BMJ Open contributor: fullname: Jefferies – volume: 375 start-page: 619 year: 2016 ident: 10.1016/j.cct.2021.106334_bb0060 article-title: Acetaminophen versus ibuprofen in young children with mild persistent asthma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1515990 contributor: fullname: Sheehan – volume: 52 start-page: 42 year: 2013 ident: 10.1016/j.cct.2021.106334_bb0080 article-title: The effect of a single dose of acetaminophen on airways response in children with asthma publication-title: Clin. Pediatr. (Phila) doi: 10.1177/0009922812462764 contributor: fullname: Soferman – volume: 41 start-page: 399 year: 2011 ident: 10.1016/j.cct.2021.106334_bb0035 article-title: The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort publication-title: Clin. Exp. Allergy doi: 10.1111/j.1365-2222.2010.03610.x contributor: fullname: Wickens – volume: 171 start-page: 966 year: 2005 ident: 10.1016/j.cct.2021.106334_bb0030 article-title: The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.200409-1269OC contributor: fullname: McKeever – volume: 135 start-page: 441 year: 2015 ident: 10.1016/j.cct.2021.106334_bb0050 article-title: Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2014.07.065 contributor: fullname: Sordillo – volume: 116 start-page: 863 year: 2005 ident: 10.1016/j.cct.2021.106334_bb0025 article-title: Use of acetaminophen and the risk of self-reported allergic symptoms and skin sensitization in Butajira, Ethiopia publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2005.05.045 contributor: fullname: Davey – volume: 127 start-page: 580 year: 2011 ident: 10.1016/j.cct.2021.106334_bb0075 article-title: Fever and antipyretic use in children publication-title: Pediatrics doi: 10.1542/peds.2010-3852 contributor: fullname: Sullivan – volume: 35 start-page: 18 year: 2005 ident: 10.1016/j.cct.2021.106334_bb0095 article-title: Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood publication-title: Clin. Exp. Allergy doi: 10.1111/j.1365-2222.2005.02151.x contributor: fullname: Shaheen – volume: 120 start-page: S94 year: 2007 ident: 10.1016/j.cct.2021.106334_bb0070 article-title: Guidelines for the diagnosis and management of asthma - Summary Report 2007 publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2007.09.029 contributor: fullname: (EPR-3) EPR – volume: 372 start-page: 1039 year: 2008 ident: 10.1016/j.cct.2021.106334_bb0015 article-title: Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme publication-title: Lancet doi: 10.1016/S0140-6736(08)61445-2 contributor: fullname: Beasley – volume: 109 year: 2002 ident: 10.1016/j.cct.2021.106334_bb0010 article-title: Asthma morbidity after the short-term use of ibuprofen in children publication-title: Pediatrics doi: 10.1542/peds.109.2.e20 contributor: fullname: Lesko – volume: 65 start-page: 118 year: 2010 ident: 10.1016/j.cct.2021.106334_bb0090 article-title: Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort publication-title: Thorax doi: 10.1136/thx.2009.121459 contributor: fullname: Perzanowski – volume: 126 start-page: 1071 year: 2010 ident: 10.1016/j.cct.2021.106334_bb0055 article-title: Respiratory tract infections and not paracetamol medication during infancy are associated with asthma development in childhood publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2010.08.023 contributor: fullname: Schnabel – volume: 41 start-page: S20 issue: Suppl. 1 year: 2010 ident: 10.1016/j.cct.2021.106334_bb0005 article-title: Challenging issues in randomised controlled trials publication-title: Injury doi: 10.1016/j.injury.2010.03.033 contributor: fullname: Nichol – volume: 4 year: 2014 ident: 10.1016/j.cct.2021.106334_bb0085 article-title: Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults publication-title: BMJ Open doi: 10.1136/bmjopen-2013-004324 contributor: fullname: Ioannides – volume: 138 year: 2016 ident: 10.1016/j.cct.2021.106334_bb0065 article-title: Individualized therapy for persistent asthma in young children publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2016.09.028 contributor: fullname: Fitzpatrick – volume: 183 start-page: 171 year: 2011 ident: 10.1016/j.cct.2021.106334_bb0020 article-title: Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.201005-0757OC contributor: fullname: Beasley – volume: 124 start-page: 446 year: 2009 ident: 10.1016/j.cct.2021.106334_bb0040 article-title: Medication use among children <12 years of age in the United States: results from the Slone Survey publication-title: Pediatrics doi: 10.1542/peds.2008-2869 contributor: fullname: Vernacchio – volume: 128 start-page: 1181 year: 2011 ident: 10.1016/j.cct.2021.106334_bb0045 article-title: The association of acetaminophen and asthma prevalence and severity publication-title: Pediatrics doi: 10.1542/peds.2011-1106 contributor: fullname: McBride – volume: 45 start-page: 448 year: 2015 ident: 10.1016/j.cct.2021.106334_bb0100 article-title: Randomized controlled trial of asthma risk with paracetamol use in infancy--a feasibility study publication-title: Clin. Exp. Allergy doi: 10.1111/cea.12433 contributor: fullname: Riley |
SSID | ssj0036565 |
Score | 2.2950687 |
Snippet | When conducting clinical trials comparing over-the-counter (OTC) medications, the wide availability of these treatments are a potential challenge to... BACKGROUND/AIMSWhen conducting clinical trials comparing over-the-counter (OTC) medications, the wide availability of these treatments are a potential... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 106334 |
SubjectTerms | Acetaminophen Asthma Asthma - drug therapy Child Children Double-Blind Method Humans Ibuprofen Randomized controlled trial |
Title | Adherence rates during a randomized controlled trial evaluating the use of blinded acetaminophen and ibuprofen in children with asthma |
URI | https://dx.doi.org/10.1016/j.cct.2021.106334 https://www.ncbi.nlm.nih.gov/pubmed/33652129 https://search.proquest.com/docview/2496247216 https://pubmed.ncbi.nlm.nih.gov/PMC8180511 |
Volume | 104 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVqq4INryWKCVK_WEFNZZO7H3uFq1WqCtEFCpN8uxJ9qgrrdisxcOHPndzOSx6oLgwClx4iTWzNgzjr_5zNiZKoUTJkjsaUYmyniTFEJD4hV2jyJoX4YGbXGdz27U-9vsdodN-1wYglV2Y387pjejdXdl2ElzeF9Vw8_k7DXOB0b0i1o3GeUK3R_a9NsfG5iHxHglazhTszSh2v3KZoPx8p7glKMUy7mU6m--6c_Y83cI5QOfdPGEPe6CST5p23vAdiAesv2rbrn8iP2chHmbzseJEWLF26RE7rAYw3JRfYfAO7D6HZ42W3jwngAcK2J0yNcr4MuSF3dErBi481C7RRWJjyByfA2vijXt_I2lKvI-OZzTD17uVvV84Z6ym4vzL9NZ0m28gCoSsk60NKC9HtPEGQVbogtLlYexNBrQuTmfg0pNEM6MhVf43ZAZV0KZCZ8LMEI-Y7txGeEF4x4yjSGH9gUKH3IwmU49lM4ol2Ye3IC96UVu71t-DdsDz75a1I8l_dhWPwOmeqXYLSOxOP7_67HTXoEWOw-tiLgIy_XK4twzHyniLxqw561CN62QaDro18cDprdUvalAxNzbd2I1bwi6KX8eA9mX_9fcV-wRlVpU5Wu2W39bwzFGPnVx0pj2CdubTD9dfqTjuw-z619WRAcT |
link.rule.ids | 230,315,783,787,888,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQSG0viL6XPjBST5XSddZO7D0iVLTldSlI3CzHnmhTsV7EZi8cOPK7O5PHqltUDr3FsZNYM2PPOP7mM2NfVCmcMEHiSDMyUcabpBAaEq9weBRB-zI0aIvzfHKpjq-yqw122OfCEKyym_vbOb2Zrbs7w06aw5uqGv4kZ69xPTCiX9SaMsq3FMXHaNTf7lc4D4kBS9aQpmZpQs37rc0G5OU94SlHKZZzKdW_nNPj4PNvDOUfTuloh2130SQ_aDv8km1AfMWenXX75a_Zw0GYtvl8nCghFrzNSuQOizHMZ9UdBN6h1a_xsjnDg_cM4NgQw0O-XACfl7y4JmbFwJ2H2s2qSIQEkeNreFUs6ehvLFWR99nhnP7wcreopzP3hl0efb84nCTdyQuoIyHrREsD2usxrZxRsiX6sFR5GEujAb2b8zmo1AThzFh4hd8NmXEllJnwuQAj5Fu2GecR3jPuIdMYc2hfoPAhB5Pp1EPpjHJp5sEN2Nde5PamJdiwPfLsl0X9WNKPbfUzYKpXil2zEosO4KnH9nsFWhw9tCXiIsyXC4uLz3ykiMBowN61Cl31QqLpoGMfD5heU_WqATFzr9fEatowdFMCPUayu__X3T32fHJxdmpPf5yffGAvqKaFWH5km_XtEj5hGFQXnxsz_w0nNAcX |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adherence+rates+during+a+randomized+controlled+trial+evaluating+the+use+of+blinded+acetaminophen+and+ibuprofen+in+children+with+asthma&rft.jtitle=Contemporary+clinical+trials&rft.au=Sheehan%2C+William+J&rft.au=Paul%2C+Ian+M&rft.au=Mauger%2C+David+T&rft.au=Moy%2C+James+N&rft.date=2021-05-01&rft.eissn=1559-2030&rft.volume=104&rft.spage=106334&rft.epage=106334&rft_id=info:doi/10.1016%2Fj.cct.2021.106334&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1551-7144&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1551-7144&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1551-7144&client=summon |